VitaCig Provides Corporate Update

BEVERLY HILLS, CA--(Marketwired - Dec 10, 2015) - VitaCig, Inc. (OTC PINK: VTCQ) Company, a technology company that is harnessing mobile vaporization technology for medical delivery applications as well as a leader in the development, marketing, and sales of high-end consumer Hemp CBD Oil and Tinctures, Edibles, and E-Liquids (E-Juices) offers an update to its shareholders.

"We are extremely excited about the decision to officially re-launch the company and brand over the next few weeks and months," said Paul Rosenberg, Chief Executive Officer of VitaCig. "We want to thank all shareholders for their patience during this lengthy quiet period, and want to reassure investors we are dedicated to maintaining minimal costs and increasing long-term value will continue to be our top priority."

Over the next few weeks and months, the company will be rolling out a host of new and innovative products under the VitaCig brand, including the very latest addition to our product line, VitaCBD™. The scientifically formulated Organic Grade Hemp CBD Oil will be sold under VitaCig Inc. and distributed by mCig, a leading distributor of other CBD and vape products. VitaCBD™, since its launch last month, has received a remarkable reception in the industry, and is already bringing in significant revenue for the company. Both VitaCig and mCig will continue to work together in developing and distributing a full line of world class VitaCBD™ products.

Next week VitaCig will launch two new All-Natural Flavored High Grade Hemp CBD Vape Oils (E-Juices) just in time for the finish to the holiday shopping season. In addition, VitaCig will be introducing Vita Chocolate with CBD to its expanding product line. This new product offering will enrich your body, as well as your palate, and is sure to be one of our best sellers.

On the horizon for 2016, VitaCig will also be developing a nicotine and caffeine line of products to complement our existing VitaCig line and brand. VitaCig continues to see international success with our Vitastik partners and affiliates in Germany, UK, Australia, Japan and South Korea, and is currently in the process of re-negotiating the terms of some of these partnerships as we speak. We expect to add to our global partner resume over the next several months as deals become finalized. On a national level, VitaCig will be enlisting sales reps of their own as well as using the experienced sales team at MCIG to aggressively get our products into retail shops all across the country. We will initiate several well-orchestrated online social media campaigns and strategic online marketing to draw customers to our online website.

We also expect over the next few months to unveil a newly redesigned corporate website, intended to enrich the online user experience.

VitaCig is actively seeking out a new CEO, as well as key management personnel, to take over day to day operations and effectively run our aggressive business plan. We are considering several candidates, and will provide an update as soon as a decision has been made. We expect to see increasing revenue growth over the next few quarters and will be doing so without taking on toxic debt or major dilution, very uncommon amongst our peers.

Despite being a SEC fully reporting company, we understand the desire of our shareholders to up list to a higher exchange, as in OTCQB. Following the acquisition of a new CEO, we will encourage him/her, to make that a top priority. Again we thank shareholders for their patience and we are more focused than ever at increasing value for investors. We are looking forward to new beginnings here at VitaCig, and an incredible year ahead for 2016. Stay tuned for future updates!

About VitaCig, Inc.

VitaCig, Inc. (OTC PINK: VTCQ) is a technology company harnessing mobile vaporization technology for medical delivery applications. The company owns, manufactures, and distributes the VitaCig®, a nicotine-free device.

Safe Harbor Statement

Any statements contained in this press release that do not describe historical facts may constitute forward-looking statements as that term is defined in the Private Securities Litigation Reform Act of 1995. Any forward-looking statements contained herein are based on current expectations, but are subject to a number of risks and uncertainties. The factors that could cause actual future results to differ materially from current expectations include, but are not limited to, risks and uncertainties relating to the Company's ability to develop, market and sell products based on its technology; the expected benefits and efficacy of the Company's products and technology; the availability of substantial additional funding for the Company to continue its operations and to conduct research and development, and future product commercialization; and the Company's business, research, product development, regulatory approval, marketing and distribution plans and strategies.